These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28661267)

  • 21. The Utility of Ankle-Brachial Index as a Predictor of Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage.
    Guan J; Karsy M; Brock A; Couldwell WT
    World Neurosurg; 2016 May; 89():139-46. PubMed ID: 26828462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case control study of statin and magnesium administration in patients after aneurysmal subarachnoid hemorrhage: incidence of delayed cerebral ischemia and mortality.
    Kerz T; Victor A; Beyer C; Trapp I; Heid F; Reisch R
    Neurol Res; 2008 Nov; 30(9):893-7. PubMed ID: 18691455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statin-treated patients with aneurysmal subarachnoid haemorrhage: a meta-analysis.
    Zhu RL; Chen ZJ; Li S; Lu XC; Tang LJ; Huang BS; Yu W; Wang X; Qian TD; Li LX
    Eur Rev Med Pharmacol Sci; 2016 May; 20(10):2090-8. PubMed ID: 27249609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelin-receptor antagonists for aneurysmal subarachnoid hemorrhage: an updated meta-analysis of randomized controlled trials.
    Ma J; Huang S; Ma L; Liu Y; Li H; You C
    Crit Care; 2012 Oct; 16(5):R198. PubMed ID: 23078672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic magnesium sulfate for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Reddy D; Fallah A; Petropoulos JA; Farrokhyar F; Macdonald RL; Jichici D
    Neurocrit Care; 2014 Oct; 21(2):356-64. PubMed ID: 24619389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial.
    Kirkpatrick PJ; Turner CL; Smith C; Hutchinson PJ; Murray GD;
    Lancet Neurol; 2014 Jul; 13(7):666-75. PubMed ID: 24837690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiplatelet therapy in aneurysmal subarachnoid hemorrhage: a systematic review.
    Dorhout Mees SM; Rinkel GJ; Hop JW; Algra A; van Gijn J
    Stroke; 2003 Sep; 34(9):2285-9. PubMed ID: 12881605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of ABO Blood Group in Cerebral Vasospasm, Associated Intracranial Hemorrhage, and Delayed Cerebral Ischemia in 470 Patients with Subarachnoid Hemorrhage.
    Dubinski D; Won SY; Konczalla J; Mersmann J; Geisen C; Herrmann E; Seifert V; Senft C
    World Neurosurg; 2017 Jan; 97():532-537. PubMed ID: 27777156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnesium sulphate in the management of patients with aneurysmal subarachnoid haemorrhage: a meta-analysis of prospective controlled trials.
    Ma L; Liu WG; Zhang JM; Chen G; Fan J; Sheng HS
    Brain Inj; 2010; 24(5):730-5. PubMed ID: 20334471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIMALAIA (Hypertension Induction in the Management of AneurysmaL subArachnoid haemorrhage with secondary IschaemiA): a randomized single-blind controlled trial of induced hypertension vs. no induced hypertension in the treatment of delayed cerebral ischemia after subarachnoid hemorrhage.
    Gathier CS; van den Bergh WM; Slooter AJ;
    Int J Stroke; 2014 Apr; 9(3):375-80. PubMed ID: 23692645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of simvastatin in prevention of vasospasm and improving functional outcome after aneurysmal sub-arachnoid hemorrhage: a prospective, randomized, double-blind, placebo-controlled pilot trial.
    Garg K; Sinha S; Kale SS; Chandra PS; Suri A; Singh MM; Kumar R; Sharma MS; Pandey RM; Sharma BS; Mahapatra AK
    Br J Neurosurg; 2013 Apr; 27(2):181-6. PubMed ID: 23298376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa.
    Lanzino G; Kassell NF; Dorsch NW; Pasqualin A; Brandt L; Schmiedek P; Truskowski LL; Alves WM
    J Neurosurg; 1999 Jun; 90(6):1011-7. PubMed ID: 10350245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toll-like receptor 4 (TLR4) is correlated with delayed cerebral ischemia (DCI) and poor prognosis in aneurysmal subarachnoid hemorrhage.
    Ma C; Zhou W; Yan Z; Qu M; Bu X
    J Neurol Sci; 2015 Dec; 359(1-2):67-71. PubMed ID: 26671088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Matsuda N; Naraoka M; Ohkuma H; Shimamura N; Ito K; Asano K; Hasegawa S; Takemura A
    Cerebrovasc Dis; 2016; 42(1-2):97-105. PubMed ID: 27070952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraventricular Recombinant Tissue Plasminogen Activator in Treatment of Aneurysmal Intraventricular Hemorrhage: A Meta-Analysis.
    Shi L; Xu L; Shi L; Brandon D; Chen S; Zhang J
    Curr Drug Targets; 2017; 18(12):1399-1407. PubMed ID: 26343113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simvastatin for the prevention of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a single-institution prospective cohort study.
    McGirt MJ; Garces Ambrossi GL; Huang J; Tamargo RJ
    J Neurosurg; 2009 May; 110(5):968-74. PubMed ID: 19199459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholesterol-Reducing Agents for Treatment of Aneurysmal Subarachnoid Hemorrhage: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Akhigbe T; Zolnourian A; Bulters D
    World Neurosurg; 2017 May; 101():476-485. PubMed ID: 28192263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage.
    Kramer AH; Gurka MJ; Nathan B; Dumont AS; Kassell NF; Bleck TP
    Neurosurgery; 2008 Feb; 62(2):422-7; discussion 427-30. PubMed ID: 18382320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature.
    Velat GJ; Kimball MM; Mocco JD; Hoh BL
    World Neurosurg; 2011 Nov; 76(5):446-54. PubMed ID: 22152574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.